NewsRoom Articles - Page 249 of 603

TuesdayAug 10, 2021 11:40 am

Flora Growth Corp. (NASDAQ: FLGC) Inks 2 LOIs to Boost CBD Product Distribution in Australia, Latin America

Flora Growth Corp. is a Colombian cannabis cultivator that is building a global cannabis CPG portfolio of premium brands and products Flora Growth recently announced an LOI designed to grant it an in-road to Australia’s over-the-counter medical cannabis and CBD commercial markets The company also signed an LOI to distribute popular Canadian pain topical brand KaLaya throughout Latin American countries, with exports planned to the United States, and to infuse its established line of products with CBD Market analysts predict Australia’s medial cannabis market will explode from about $150 million this year to more than a billion dollars by 2025…

TuesdayAug 10, 2021 4:20 am

420 with CNW — Senate Leaders Release Infrastructure Deal Seeking to Allow Studies Using Cannabis from Dispensaries

Earlier this week, Senate leaders released a bipartisan infrastructure legislation that includes provisions that permit researchers to conduct studies on the cannabis that consumers are purchasing from dispensaries in legal states. Prior to this, researchers were only allowed to conduct research on government-grown marijuana. In addition, the legislation encourages states that have enacted marijuana legalization laws to educate individuals on impaired driving. The legislation also stipulates that the Health and Human Services Secretary and the Attorney General compile a report two years after the legislation's enactment that would include recommendations on permitting researchers to access retail-level cannabis, which would allow…

MondayAug 09, 2021 4:20 pm

420 with CNW — What the Future Holds for Hemp-Sourced Cannabinoids

In the early 1970s, the federal government outlawed all cannabis cultivation, and failing to distinguish between hemp and its psychoactive cousin cannabis, declared it illegal to cultivate both cannabis and hemp. These policies held for decades, and while the illicit market continued supplying cannabis, hemp nearly faded into obscurity. In 2014, Congress passed a farm bill that allowed state agriculture departments and universities to grow hemp in pilot programs as long as their home states permitted it. Four years later, the 2018 farm gill removed hemp from the list of controlled substances, allowing the cultivation, processing and sale of hemp…

MondayAug 09, 2021 2:25 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Subsidiary Inks Deal to Provide Limited-Edition Alkaline Spring Water to BC Firefighters

Naturo Group signs contract with BC Wildfire Services Division; will provide special bottled water to over 1,100 firefighters across British Columbia. TRACE-branded natural 7.7ph alkaline spring water is sourced directly the source in British Columbia, the very land the firefighters protect. BevCanna’s TRACE product line features unique, ancient minerals that offer a broad range of wellness properties including cognitive performance, immune function and gut health. BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has announced that its wholly owned subsidiary Naturo Group has been selected to manufacture and supply a special, limited-edition run of its TRACE-branded, alkaline spring water to…

MondayAug 09, 2021 1:51 pm

Flora Growth Corp. (NASDAQ: FLGC) Receives Fair Value Estimate, Coverage from Argus Research Company; Developing Growth Opportunities by Columbia’s Cannabis Law, Headquarter Relocation

Flora Growth Corp recently received coverage from Argus Research, which gives the company’s stock a fair value estimate of $7.50 against the $3.24 recorded July 20 Argus also projects that Flora’s revenue would increase to $9 million in 2021 and $31 million in 2022, up from $0.1 million reported in 2020 Flora received a boost in its operations when Colombia’s president accepted and signed reforms to the existing cannabis legislation The updated law allows for the manufacture, sale and export of psychoactive (high-THC) cannabinoid ingestible and medical products and removes marketing limitations on cannabis products in Colombia Flora is also…

MondayAug 09, 2021 1:06 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) and Its Quest to Build an Industry-Leading, Rare Cannabinoid Enterprise

InMed announced a non-binding letter of intent to acquire BayMedica Inc. The move is designed to grow InMed’s market presence and strengthen its operations The two companies have had a reciprocal research collaboration that dates back to November 2020 InMed looks to capitalize on the growing cannabinoid industry that is projected to grow at a CAGR of 21.2% from 2021 to 2028 InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company committed to developing cannabinoid-based pharmaceutical drug candidates. It also manufactures technologies for pharmaceutical-grade rare cannabinoids. It is known for creating a pipeline of cannabinoid-based pharmaceutical drug candidates to treat various…

MondayAug 09, 2021 4:20 am

420 with CNW — Patients with High-Grade Gliomas Register Improved Quality of Life after Using Medical Marijuana

The past few decades have seen cannabis progress from an intensely policed drug with no perceived medical applications to a “miracle drug” with a plethora of health benefits. Anecdotal reports and preliminary studies have found it to be effective against, among other things, chronic pain, anxiety insomnia, nausea and vomiting, which are incidentally the symptoms often endured by individuals suffering from cancer who are undergoing chemotherapy. Thanks to restrictive cannabis policies, few researchers have been able to conclusively study how cannabis affects the quality of life of cancer patients. However, a recent study published in “Frontiers in Oncology” sought to…

FridayAug 06, 2021 4:20 pm

420 with CNW — Why Investors Interested in Cannabis Should Expect a Big Stock Surge

At the moment, more than 100 million residents in the United States live in a state that has legalized recreational cannabis, with a whopping 95% living in a state with a legal medical cannabis system in place. Cannabis multistate operators are readying themselves for the next huge stock increase, which is expected to happen even without a change in federal legislations. Marijuana is fast closing the revenue gap, especially with the emergence of profitability, after the huge infrastructure spending that began in 2018 and 2019. Trading indexes show favorable valuations throughout this season, despite the imminent federal legislative gridlock. Marijuana…

FridayAug 06, 2021 9:30 am

First Results from Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Show Marked Gains in Blood Pressure Reduction over Generic CBD Controls

Drug delivery platform developer Lexaria Bioscience has developed its patented DehydraTECH(TM) as a means of transforming pharmaceuticals that increases their bioavailability and speed of efficacy Ongoing testing of DehydraTECH in combination with cannabidiol (“CBD”) is analyzing DehydraTECH’s responsiveness to hypertension conditions that are targeted in heart disease and stroke therapies Partial results from the company’s first study indicate Lexaria’s DehydraTECH platform, when processed with CBD, reduces blood pressure and does so much more rapidly when compared with the generic CBD controls The complete results of the study will be produced as sample and data analyses work are completed Lexaria is…

FridayAug 06, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Sees Important Trends in Sports Medicine and Plant-Therapy

As U.S. research restrictions are lifted there is a rising interest in the use of plant-therapy in sports medicine Cannabis in sports medicine took center stage at the Tokyo Olympics American athletes are turning more and more to cannabis as a pain reliever, alternative to opioids, and part of an overall sports recovery plan RYAH Group (CSE: RYAH) (formerly RYAH Medtech), the leader in dose-control technology for plant-based medicine, works with researchers to provide a full turnkey solution for clinical studies from start to finish. RYAH Group's dose-control devices standardize the dosing protocol, QR products ensure compliance, and mobile apps…

News and publishing service for cannabis related companies

Contact us: 512.354.7000